{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:58:38Z","timestamp":1793336318481,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To provide a consensus statement and recommendations on MR imaging in primary sclerosing cholangitis (PSC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The European Society of Gastrointestinal and Abdominal Radiology (ESGAR) convened a multinational European panel of experts selected based on a literature review and their leadership in the field. A modified Delphi process was adopted to draft a list of statements. For each statement, the panelists indicated the level of agreement using a 5-point Likert scale, where 1 means \u201cno agreement,\u201d 2 means \u201cpoor agreement,\u201d 3 means \u201cslight agreement,\u201d 4 means \u201cfair agreement,\u201d and 5 means \u201ccomplete agreement.\u201d The median score for each statement was collected. The level of evidence was reported according to the Oxford Centre for Evidence-Based Medicine. Descriptive statistics were used to rate agreement levels and the consensus\u2019 internal reliability.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The 12 voting committee members were from Italy (<jats:italic>n<\/jats:italic>\u2009=\u20094, 33.4%), Austria (<jats:italic>n<\/jats:italic>\u2009=\u20092, 16.7%), Sweden (<jats:italic>n<\/jats:italic>\u2009=\u20091, 8.3%), France (<jats:italic>n<\/jats:italic>\u2009=\u20091, 8.3%), the United States (<jats:italic>n<\/jats:italic>\u2009=\u20091, 8.3%), Switzerland (<jats:italic>n<\/jats:italic>\u2009=\u20091, 8.3%), and Belgium (<jats:italic>n<\/jats:italic>\u2009=\u20092, 16.7%). The final questionnaire consisted of 55 statements. The agreement reached by the expert panel was complete for 23 statements (41.8%), fair for 16 (29.1%), slight for 15 (27.2%), and poor for 1 (1.9%). Statements that received complete agreement were used to structure a reporting template.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This statement paper recommends how and when to perform MRI in PSC patients. A structured reporting template has been created to improve quality care and communication among radiologists and clinicians.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Question<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>A standard MR protocol and the most common imaging features to be reported are fundamental for the correct evaluation of primary sclerosing cholangitis (PSC) patients.<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Findings<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>Twelve expert radiologists reported which are the most important imaging features and how and when to perform MR in PSC patients.<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Clinical relevance<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>The identified statements reported in this paper and the structured reporting template are useful for radiologists and clinicians to help correctly manage PSC patients.<\/jats:italic>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00330-025-11583-4","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T01:36:15Z","timestamp":1745631375000},"page":"6495-6506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["ESGAR consensus statement on MR imaging in primary sclerosing cholangitis"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2696-7047","authenticated-orcid":false,"given":"Davide","family":"Ippolito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Maino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Arriv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ba-Ssalamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristeidis","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pezzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"P\u00f6etter Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schmidt Kobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Vernuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"11583_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis KN, LaRusso NF (2016) Primary sclerosing cholangitis. N Engl J Med 375:1161\u20131170. https:\/\/doi.org\/10.1056\/NEJMra1506330","journal-title":"N Engl J Med"},{"key":"11583_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY (2012) Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 56:1181\u20131188. https:\/\/doi.org\/10.1016\/j.jhep.2011.10.025","journal-title":"J Hepatol"},{"key":"11583_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1148\/radiographics.20.4.g00jl04959","volume":"20","author":"KM Vitellas","year":"2000","unstructured":"Vitellas KM, Keogan MT, Freed KS et al (2000) Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. Radiographics 20:959\u2013975. https:\/\/doi.org\/10.1148\/radiographics.20.4.g00jl04959","journal-title":"Radiographics"},{"key":"11583_CR4","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","volume":"35","author":"SP Angulo","year":"2002","unstructured":"Angulo SP, Maor-Kendler Y, Lindor KD (2002) Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 35:1494\u20131500. https:\/\/doi.org\/10.1053\/jhep.2002.33202","journal-title":"Hepatology"},{"key":"11583_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"CL Bowlus","year":"2023","unstructured":"Bowlus CL, Arriv\u00e9 L, Bergquist A et al (2023) AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 77:659\u2013702. https:\/\/doi.org\/10.1002\/hep.32771","journal-title":"Hepatology"},{"key":"11583_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"O Chazouilleres","year":"2022","unstructured":"Chazouilleres O, Beuers U, Bergquist A et al (2022) EASL clinical practice guidelines on sclerosing cholangitis. J Hepatol 77:761\u2013806. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.011","journal-title":"J Hepatol"},{"key":"11583_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00261-022-03655-6","volume":"48","author":"MA Morgan","year":"2023","unstructured":"Morgan MA, Khot R, Sundaram KM et al (2023) Primary sclerosing cholangitis: review for radiologists. Abdom Radiol (NY) 48:136\u2013150. https:\/\/doi.org\/10.1007\/s00261-022-03655-6","journal-title":"Abdom Radiol"},{"key":"11583_CR8","doi-asserted-by":"publisher","first-page":"e7298","DOI":"10.7759\/cureus.7298","volume":"12","author":"S Deliwala","year":"2020","unstructured":"Deliwala S, Sundus S, Haykal T, Elbedawi MM, Bachuwa G (2020) Small duct primary sclerosing cholangitis: an underdiagnosed cause of chronic liver disease and cirrhosis. Cureus 12:e7298. https:\/\/doi.org\/10.7759\/cureus.7298","journal-title":"Cureus"},{"key":"11583_CR9","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1007\/s00330-021-08333-7","volume":"32","author":"SK Venkatesh","year":"2022","unstructured":"Venkatesh SK, Welle CL, Miller FH et al (2022) Correction to: Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol 32:2860. https:\/\/doi.org\/10.1007\/s00330-021-08333-7","journal-title":"Eur Radiol"},{"key":"11583_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.mric.2007.06.003","volume":"15","author":"M Ramalho","year":"2007","unstructured":"Ramalho M, Altun E, Her\u00e9dia V, Zapparoli M, Semelka R (2007) Liver MR imaging: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15:321\u2013347. https:\/\/doi.org\/10.1016\/j.mric.2007.06.003","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"11583_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.crad.2018.11.005","volume":"74","author":"M Renzulli","year":"2019","unstructured":"Renzulli M, Biselli M, Fabbri E et al (2019) What is the best fruit juice to use as a negative oral contrast agent in magnetic resonance cholangiopancreatography? Clin Radiol 74:220\u2013227. https:\/\/doi.org\/10.1016\/j.crad.2018.11.005","journal-title":"Clin Radiol"},{"key":"11583_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13244-011-0129-9","volume":"3","author":"N Griffin","year":"2012","unstructured":"Griffin N, Charles-Edwards G, Grant LA (2012) Magnetic resonance cholangiopancreatography: the ABC of MRCP. Insights Imaging 3:11\u201321. https:\/\/doi.org\/10.1007\/s13244-011-0129-9","journal-title":"Insights Imaging"},{"key":"11583_CR13","doi-asserted-by":"publisher","first-page":"109994","DOI":"10.1016\/j.ejrad.2021.109994","volume":"144","author":"T Tajima","year":"2021","unstructured":"Tajima T, Akai H, Sugawara H et al (2021) Breath-hold 3D magnetic resonance cholangiopancreatography at 1.5 T using a deep learning-based noise-reduction approach: comparison with the conventional respiratory-triggered technique. Eur J Radiol 144:109994. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109994","journal-title":"Eur J Radiol"},{"key":"11583_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1148\/rg.2020200030","volume":"40","author":"BPC Vidal","year":"2020","unstructured":"Vidal BPC, Lahan-Martins D, Penachim TJ, Rodstein MAM, Cardia PP, Prando A (2020) MR cholangiopancreatography: what every radiology resident must know. Radiographics 40:1263\u20131264. https:\/\/doi.org\/10.1148\/rg.2020200030","journal-title":"Radiographics"},{"key":"11583_CR15","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2214\/ajr.182.6.1821513","volume":"182","author":"H-M Tsai","year":"2004","unstructured":"Tsai H-M, Lin X-Z, Chen C-Y, Lin P-W, Lin J-C (2004) MRI of gallstones with different compositions. AJR Am J Roentgenol 182:1513\u20131519. https:\/\/doi.org\/10.2214\/ajr.182.6.1821513","journal-title":"AJR Am J Roentgenol"},{"key":"11583_CR16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3748\/wjg.v16.i13.1567","volume":"16","author":"PG Kele","year":"2010","unstructured":"Kele PG (2010) Diffusion weighted imaging in the liver. World J Gastroenterol 16:1567. https:\/\/doi.org\/10.3748\/wjg.v16.i13.1567","journal-title":"World J Gastroenterol"},{"key":"11583_CR17","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00330-018-5614-9","volume":"29","author":"S Keller","year":"2019","unstructured":"Keller S, Sedlacik J, Schuler T et al (2019) Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis. Eur Radiol 29:818\u2013828. https:\/\/doi.org\/10.1007\/s00330-018-5614-9","journal-title":"Eur Radiol"},{"key":"11583_CR18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00330-015-3900-3","volume":"26","author":"E Neri","year":"2016","unstructured":"Neri E, Bali MA, Ba-Ssalamah A et al (2016) ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. Eur Radiol 26:921\u2013931. https:\/\/doi.org\/10.1007\/s00330-015-3900-3","journal-title":"Eur Radiol"},{"key":"11583_CR19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00330-021-08147-7","volume":"32","author":"SK Venkatesh","year":"2022","unstructured":"Venkatesh SK, Welle CL, Miller FH et al (2022) Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol 32:923\u2013937. https:\/\/doi.org\/10.1007\/s00330-021-08147-7","journal-title":"Eur Radiol"},{"key":"11583_CR20","doi-asserted-by":"publisher","first-page":"100595","DOI":"10.1016\/j.jhepr.2022.100595","volume":"4","author":"A Grigoriadis","year":"2022","unstructured":"Grigoriadis A, Imeen Ringe K, Bengtsson J et al (2022) Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis. JHEP Rep 4:100595. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100595","journal-title":"JHEP Rep"},{"key":"11583_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1148\/radiographics.21.1.g01ja093","volume":"21","author":"MA Turner","year":"2001","unstructured":"Turner MA, Fulcher AS (2001) The cystic duct: normal anatomy and disease processes. Radiographics 21:3\u201322. https:\/\/doi.org\/10.1148\/radiographics.21.1.g01ja093","journal-title":"Radiographics"},{"key":"11583_CR22","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.29293","volume":"66","author":"C Schramm","year":"2017","unstructured":"Schramm C, Eaton J, Ringe KI, Venkatesh S, Yamamura J (2017) Recommendations on the use of magnetic resonance imaging in PSC\u2014a position statement from the International PSC Study Group. Hepatology 66:1675\u20131688. https:\/\/doi.org\/10.1002\/hep.29293","journal-title":"Hepatology"},{"key":"11583_CR23","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1148\/rg.2019180213","volume":"39","author":"P Khoshpouri","year":"2019","unstructured":"Khoshpouri P, Habibabadi RR, Hazhirkarzar B et al (2019) Imaging features of primary sclerosing cholangitis: from diagnosis to liver transplant follow-up. Radiographics 39:1938\u20131964. https:\/\/doi.org\/10.1148\/rg.2019180213","journal-title":"Radiographics"},{"key":"11583_CR24","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1148\/rg.296095512","volume":"29","author":"SC Faria","year":"2009","unstructured":"Faria SC, Ganesan K, Mwangi I et al (2009) MR imaging of liver fibrosis: current state of the art. Radiographics 29:1615\u20131635. https:\/\/doi.org\/10.1148\/rg.296095512","journal-title":"Radiographics"},{"key":"11583_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1148\/radiographics.22.5.g02se061023","volume":"22","author":"SM Hussain","year":"2002","unstructured":"Hussain SM, Zondervan PE, IJzermans JNM, Schalm SW, De Man RA, Krestin GP (2002) Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22:1023\u20131036. https:\/\/doi.org\/10.1148\/radiographics.22.5.g02se061023","journal-title":"Radiographics"},{"key":"11583_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00261-011-9811-0","volume":"37","author":"E Moubarak","year":"2012","unstructured":"Moubarak E, Bouvier A, Boursier J et al (2012) Portosystemic collateral vessels in liver cirrhosis: a three-dimensional MDCT pictorial review. Abdom Imaging 37:746\u2013766. https:\/\/doi.org\/10.1007\/s00261-011-9811-0","journal-title":"Abdom Imaging"},{"key":"11583_CR27","doi-asserted-by":"publisher","first-page":"734.e13","DOI":"10.1016\/j.crad.2019.05.018","volume":"74","author":"P Khoshpouri","year":"2019","unstructured":"Khoshpouri P, Hazhirkarzar B, Ameli S et al (2019) Quantitative spleen and liver volume changes predict survival of patients with primary sclerosing cholangitis. Clin Radiol 74:734.e13\u2013734.e20. https:\/\/doi.org\/10.1016\/j.crad.2019.05.018","journal-title":"Clin Radiol"},{"key":"11583_CR28","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s00261-019-01944-1","volume":"44","author":"J Swensson","year":"2019","unstructured":"Swensson J, Tirkes T, Tann M, Cui E, Sandrasegaran K (2019) Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center. Abdom Radiol (NY) 44:2111\u20132115. https:\/\/doi.org\/10.1007\/s00261-019-01944-1","journal-title":"Abdom Radiol"},{"key":"11583_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejrad.2008.01.001","volume":"70","author":"E \u00d6zkavukcu","year":"2009","unstructured":"\u00d6zkavukcu E, Erden A, Erden I (2009) Pancreatic changes in patients with primary sclerosing cholangitis: MR cholangiopancreatography and MRI findings. Eur J Radiol 70:118\u2013121. https:\/\/doi.org\/10.1016\/j.ejrad.2008.01.001","journal-title":"Eur J Radiol"},{"key":"11583_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12016-019-08764-7","volume":"58","author":"J Song","year":"2020","unstructured":"Song J, Li Y, Bowlus CL, Yang G, Leung PSC, Gershwin ME (2020) Cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC): a comprehensive review. Clin Rev Allergy Immunol 58:134\u2013149. https:\/\/doi.org\/10.1007\/s12016-019-08764-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"11583_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"PR Galle","year":"2018","unstructured":"Galle PR, Forner A, Llovet JM et al (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019","journal-title":"J Hepatol"},{"key":"11583_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"D Alvaro","year":"2023","unstructured":"Alvaro D, Gores GJ, Walicki J et al (2023) EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol 79:181\u2013208. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.010","journal-title":"J Hepatol"},{"key":"11583_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1148\/radiol.2019190734","volume":"294","author":"N Bastati","year":"2020","unstructured":"Bastati N, Beer L, Mandorfer M et al (2020) Does the functional liver imaging score derived from gadoxetic acid-enhanced MRI predict outcomes in chronic liver disease? Radiology 294:98\u2013107. https:\/\/doi.org\/10.1148\/radiol.2019190734","journal-title":"Radiology"},{"key":"11583_CR34","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s00261-020-02839-2","volume":"46","author":"S Evrimler","year":"2021","unstructured":"Evrimler S, Swensson JK, Are VS, Tirkes T, Vuppalanchi R, Akisik F (2021) Quantitative assessment of disease severity of primary sclerosing cholangitis with T1 mapping and extracellular volume imaging. Abdom Radiol (NY) 46:2433\u20132443. https:\/\/doi.org\/10.1007\/s00261-020-02839-2","journal-title":"Abdom Radiol"},{"key":"11583_CR35","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/jgh.13263","volume":"31","author":"JE Eaton","year":"2016","unstructured":"Eaton JE, Dzyubak B, Venkatesh SK et al (2016) Performance of magnetic resonance elastography in primary sclerosing cholangitis. J Gastro Hepatol 31:1184\u20131190. https:\/\/doi.org\/10.1111\/jgh.13263","journal-title":"J Gastro Hepatol"},{"key":"11583_CR36","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1007\/s00330-020-06728-6","volume":"30","author":"M Tafur","year":"2020","unstructured":"Tafur M, Cheung A, Menezes RJ et al (2020) Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography. Eur Radiol 30:3735\u20133747. https:\/\/doi.org\/10.1007\/s00330-020-06728-6","journal-title":"Eur Radiol"},{"key":"11583_CR37","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.ultrasmedbio.2020.03.025","volume":"46","author":"AB Mjelle","year":"2020","unstructured":"Mjelle AB, Fossdal G, Gilja OH, Vesterhus M (2020) Liver elastography in primary sclerosing cholangitis patients using three different scanner systems. Ultrasound Med Biol 46:1854\u20131864. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2020.03.025","journal-title":"Ultrasound Med Biol"},{"key":"11583_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00330-021-08142-y","volume":"32","author":"MF Ismail","year":"2022","unstructured":"Ismail MF, Hirschfield GM, Hansen B et al (2022) Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores. Eur Radiol 32:67\u201377. https:\/\/doi.org\/10.1007\/s00330-021-08142-y","journal-title":"Eur Radiol"},{"key":"11583_CR39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/hep.26620","volume":"59","author":"A Ruiz","year":"2014","unstructured":"Ruiz A, Lemoinne S, Carrat F, Corpechot C, Chazouill\u00e8res O, Arriv\u00e9 L (2014) Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology 59:242\u2013250. https:\/\/doi.org\/10.1002\/hep.26620","journal-title":"Hepatology"},{"key":"11583_CR40","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1016\/j.cgh.2019.03.013","volume":"17","author":"S Lemoinne","year":"2019","unstructured":"Lemoinne S, Cazzagon N, El Mouhadi S et al (2019) Simple magnetic resonance scores associate with outcomes of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 17:2785\u20132792.e3. https:\/\/doi.org\/10.1016\/j.cgh.2019.03.013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11583_CR41","doi-asserted-by":"publisher","first-page":"109884","DOI":"10.1016\/j.ejrad.2021.109884","volume":"142","author":"A Grigoriadis","year":"2021","unstructured":"Grigoriadis A, Ringe KI, Andersson M, Kartalis N, Bergquist A (2021) Assessment of prognostic value and interreader agreement of ANALI scores in patients with primary sclerosing cholangitis. Eur J Radiol 142:109884. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109884","journal-title":"Eur J Radiol"},{"key":"11583_CR42","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","DOI":"10.1136\/bmj.39489.470347.AD"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11583-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11583-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11583-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:10:14Z","timestamp":1757499014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11583-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["11583"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11583-4","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Davide Ippolito.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"C.M. is a Junior Deputy Editor of European Radiology. S.S.K. and A.B.S. are members of the Scientific Editorial Board of European Radiology (Section Editor and member: Gastrointestinal-Abdominal, respectively) and, as such, they have not participated in the selection nor review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required because of the nature of the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because of the nature of the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}